Commit To Purchase Merrimack Pharmaceuticals At $6, Earn 15.8% Annualized Using Options
April 29, 2016 at 11:38 AM EDT
Investors eyeing a purchase of Merrimack Pharmaceuticals Inc. (MACK) stock, but cautious about paying the going market price of $7.30/share, might benefit from considering selling puts among the alternative strategies at their disposal..